The FDA will require label changes that limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone to adults aged 18 years and older. In addition, the agency will require added safety information highlighting the risks of misuse, abuse, addiction, overdose, death, and slowed or difficult breathing to the “boxed warning”...